Browsing Over 390 Presentations

Sort By Upcoming First
Poster Display

30P - Male breast cancer: A rural based peripheral cancer center experience

Presentation Number
30P
Speakers
  • SACHIN KHANDELWAL (SANGRUR, India)
Date
20.11.2020
Poster Display

31P - The prognostic value of pre-treatment peripheral neutrophil-lymphocyte-ratio (NLR) and its correlation with mutant p53 expression in Indonesian triple negative breast cancer patients

Presentation Number
31P
Speakers
  • Rosita Y. Purwanto (Yogyakarta, Indonesia)
Date
20.11.2020
Poster Display

32P - Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience

Presentation Number
32P
Speakers
  • Izzet Dogan (Istanbul, Turkey)
Date
20.11.2020
Poster Display

33P - FDG-PET predictivity of pathological axillary nodal status in carcinoma breast-upfront and post-neoadjuvant chemotherapy (NACT) setting

Presentation Number
33P
Speakers
  • Krithikaa Sekar (Bangalore, India)
Date
20.11.2020
Poster Display

34P - Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies

Presentation Number
34P
Speakers
  • Meng chen Liu (Shijiazhuang, China)
Date
20.11.2020
Poster Display

35P - Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer

Presentation Number
35P
Speakers
  • Goteti Sharat Chandra (New Delhi, India)
Date
20.11.2020
Poster Display

36P - Survival in patients with contralateral breast cancer

Presentation Number
36P
Speakers
  • Sergey Kamishov (Tashkent, Uzbekistan)
Date
20.11.2020
Poster Display

37P - Correlation between haematological toxicity with quality of life in breast cancer patients after first-cycle chemotherapy

Presentation Number
37P
Speakers
  • Felix Wijovi (Tangerang, Indonesia)
Date
20.11.2020
Poster Display

Breast cancer, locally advanced

Date
20.11.2020
Poster Display

38P - Evaluation of the prognostic value of innate immunity-related biomarkers in early breast cancer (BC)

Presentation Number
38P
Speakers
  • Veronica Martini (Novara, Italy)
Date
20.11.2020
Poster Display

39P - CSF-1R inhibitor (C019199) enhances antitumor effect in combination with anti-PD-1 therapy on murine breast cancer models

Presentation Number
39P
Speakers
  • Jiani Zheng (Xiamen, China)
Date
20.11.2020
Poster Display

40P - Molecular subtypes and imaging phenotypes of breast cancer: MRI

Presentation Number
40P
Speakers
  • Yulduz N. Khatamovna (Tashkent, Uzbekistan)
Date
20.11.2020